Age (years), mean (±SD) |
|
Male | 68.7 (8.82) |
Female | 69.7 (7.27) |
Sex, n (%) |
|
Male | 102 (53%)* |
Female | 89 (47%) |
Disease duration (years), median (min-max) |
|
Male | 7 (1 - 28) |
Female | 8 (1 - 21) |
Missing | n = 1 |
Walking aid, n (%) |
|
None | 145 (75.9%) |
Walking sticks | 4 (2.1%) |
Crutches | 2 (1.0%) |
Walker | 36 (18.8%) |
Mobility scooter | 1 (0.5%) |
Combination | 3 (1.6%) |
Levodopa equivalent dose (mg), median (min-max) | 700 (0 - 2100) |
Male | 800 (0 - 2100) |
Female | 650 (100 - 1350) |
Use of other anti-Parkinson medication, n (%) |
|
No extra drugs | 60 (31.4%) |
1 extra drug | 97 (50.8%) |
2 extra drugs | 31 (16.2%) |
3 extra drugs | 2 (1.0%) |
4 extra drugs | 1 (0.5%) |